MAINTENANCE--BUDESONIDE CONTROLLED ILEAL RELEASE CAPSULE IN CHRONS DISEASE

维持--布地奈德控制回肠释放胶囊治疗慢性疾病

• 批准号: 6118936
• 负责人: MARK A PEPPERCORN
• 金额: $ 3.17万
• 依托单位: BETH ISRAEL DEACONESS MEDICAL CENTER
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/6118936
• 关键词: Crohn's disease; antiinflammatory agents; drug administration routes; drug screening /evaluation; gastrointestinal disorder chemotherapy; gastrointestinal function; glucocorticoids; human subject; human therapy evaluation; ileum; microcapsule

Maintenance continuation of a randomized, placebo controlled, multicenter clinical trial to investigate the efficacy and safety of budesonide CIR in patients with Crohn's Disease affecting the ileum and/or ascending colon.

随机、安慰剂对照、多中心的维持延续 研究布地奈德 CIR 的有效性和安全性的临床试验 患有影响回肠和/或升结肠的克罗恩病的患者。